CAPN10 alleles are associated with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3971-3976

  Gonzalez, Alejandro ^a   Abril, Eduardo ^a   Roca, Alfredo ^b   Aragón, Maria José ^c   Figueroa, Maria José ^a   Velarde, Pilar ^c   Royo, José Luis ^b   Real, Luis Miguel ^a   Ruiz, Agustín ^b  

^a Instituto Medico Serman   (Spain)

^b Hospital Virgen de las Montañas de Villamartín   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPN10 PROTEIN; GENE PRODUCT; UNCLASSIFIED DRUG; CALPAIN; CALPAIN 10;

ALLELE; ANOVULATION; CALPAIN 10 GENE; CLINICAL FEATURE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FEMALE INFERTILITY; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SPECTROFLUOROMETRY; ARTICLE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS;

FALLOPIA;

CALPAIN; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYCYSTIC OVARY SYNDROME;

EID: 85047681304     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8793     Document Type: Review

References (40)

1. Identification of follistatin as a possible trait-causing gene in polycystic ovary syndrome
2. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
3. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
4. Polycystic ovarian disease: Heritability and heterogeneity
5. How many diseases does it take to map a gene with SNPs?
6. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
7. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism
8. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
9. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome
10. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
11. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
12. Role of the mutations Trp8⇒Arg and Ile15⇒Thr of the human luteinizing hormone β-subunit in women with polycystic ovary syndrome
13. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome
14. Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome
15. Association of dopamine D2 receptor gene haplotypes with anovulation and fecundity in female Hispanics
16. Apolipoprotein E alleles in women with polycystic ovary syndrome
17. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
18. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives
19. Transmission ratio distortion at the INS-IGF2 VNTR
20. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2
21. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans
22. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
23. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom
24. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans
25. Calpain 10: The first positional cloning of a gene for type 2 diabetes?
26. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
27. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach
28. Fluorescence resonance energy transfer analysis of CCR-V64I and SDF1-3′ a polymorphisms: Prevalence in southern Spain HIV type 1+ cohort and noninfected population
29. Detection of nucleotide c985 A→G mutation of medium-chain acyl-CoA dehydrogenase gene by real-time PCR
30. Novel technique for scanning of codon 634 of the RET protooncogene with fluorescence resonance energy transfer and real-time PCR in patients with medullary thyroid carcinoma
31. Hypersecretion of androgens by polycystic ovaries: The role of genetic factors in the regulation of cytochrome P450c17 α
32. Expression of the genes encoding the insulin-like growth factors and their receptors in human ovary
33. Anatomy of the human ovarian insulin-like growth factor system
34. Expression of the genes encoding the insulin-like growth factors, the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries
35. Effects of epidermal growth factor and insulin-like factor I on the levels of mRNA encoding aromatase cytochrome P-450 of human ovarian granulosa cells
36. Ovarian follicle atresia: A hormonally controlled apoptotic process
37. Insulin-like growth factor binding proteins in healthy and atretic follicles during natural menstrual cycles
38. Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa IGF-BP levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries
39. Insulin-like growth factor binding proteins: Do they play a role in polycystic ovary syndrome?
40. Insulin-like growth factor-I (IGF-I), IGF-II, IGF binding protein (IGFBP) and IGFBP proteases are produced theca and stroma of normal and PCOS human ovaries